Highlights

[GREENYB] QoQ TTM Result on 2011-04-30 [#3]

Stock [GREENYB]: GREENYIELD BHD
Announcement Date 23-Jun-2011
Admission Sponsor -
Sponsor -
Financial Year 31-Jul-2011
Quarter 30-Apr-2011  [#3]
Profit Trend QoQ -     -17.37%    YoY -     5.07%
Quarter Report


View:


Show?  QoQ % Horiz. %

TTM Result
31/01/12 31/10/11 31/07/11 30/04/11 31/01/11 31/10/10 31/07/10 CAGR
Revenue 52,093 53,790 48,239 47,690 47,175 42,385 38,779 21.68%
  QoQ % -3.15% 11.51% 1.15% 1.09% 11.30% 9.30% -
  Horiz. % 134.33% 138.71% 124.39% 122.98% 121.65% 109.30% 100.00%
PBT 10,657 11,362 9,497 9,289 11,482 10,317 9,648 6.84%
  QoQ % -6.20% 19.64% 2.24% -19.10% 11.29% 6.93% -
  Horiz. % 110.46% 117.77% 98.43% 96.28% 119.01% 106.93% 100.00%
Tax -2,427 -2,626 -2,171 -2,573 -3,356 -2,734 -2,542 -3.03%
  QoQ % 7.58% -20.96% 15.62% 23.33% -22.75% -7.55% -
  Horiz. % 95.48% 103.30% 85.41% 101.22% 132.02% 107.55% 100.00%
NP 8,230 8,736 7,326 6,716 8,126 7,583 7,106 10.26%
  QoQ % -5.79% 19.25% 9.08% -17.35% 7.16% 6.71% -
  Horiz. % 115.82% 122.94% 103.10% 94.51% 114.35% 106.71% 100.00%
NP to SH 8,230 8,736 7,326 6,716 8,128 7,586 7,109 10.22%
  QoQ % -5.79% 19.25% 9.08% -17.37% 7.14% 6.71% -
  Horiz. % 115.77% 122.89% 103.05% 94.47% 114.33% 106.71% 100.00%
Tax Rate 22.77 % 23.11 % 22.86 % 27.70 % 29.23 % 26.50 % 26.35 % -9.25%
  QoQ % -1.47% 1.09% -17.47% -5.23% 10.30% 0.57% -
  Horiz. % 86.41% 87.70% 86.76% 105.12% 110.93% 100.57% 100.00%
Total Cost 43,863 45,054 40,913 40,974 39,049 34,802 31,673 24.17%
  QoQ % -2.64% 10.12% -0.15% 4.93% 12.20% 9.88% -
  Horiz. % 138.49% 142.25% 129.17% 129.37% 123.29% 109.88% 100.00%
Net Worth 47,256 48,528 46,328 44,887 42,270 42,525 41,344 9.29%
  QoQ % -2.62% 4.75% 3.21% 6.19% -0.60% 2.86% -
  Horiz. % 114.30% 117.37% 112.05% 108.57% 102.24% 102.86% 100.00%
Dividend
31/01/12 31/10/11 31/07/11 30/04/11 31/01/11 31/10/10 31/07/10 CAGR
Div 0 0 0 0 0 0 0 -
  QoQ % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
Div Payout % - % - % - % - % - % - % - % -
  QoQ % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
Equity
31/01/12 31/10/11 31/07/11 30/04/11 31/01/11 31/10/10 31/07/10 CAGR
Net Worth 47,256 48,528 46,328 44,887 42,270 42,525 41,344 9.29%
  QoQ % -2.62% 4.75% 3.21% 6.19% -0.60% 2.86% -
  Horiz. % 114.30% 117.37% 112.05% 108.57% 102.24% 102.86% 100.00%
NOSH 333,499 166,363 166,410 165,757 166,026 163,750 163,095 60.89%
  QoQ % 100.46% -0.03% 0.39% -0.16% 1.39% 0.40% -
  Horiz. % 204.48% 102.00% 102.03% 101.63% 101.80% 100.40% 100.00%
Ratio Analysis
31/01/12 31/10/11 31/07/11 30/04/11 31/01/11 31/10/10 31/07/10 CAGR
NP Margin 15.80 % 16.24 % 15.19 % 14.08 % 17.23 % 17.89 % 18.32 % -9.37%
  QoQ % -2.71% 6.91% 7.88% -18.28% -3.69% -2.35% -
  Horiz. % 86.24% 88.65% 82.91% 76.86% 94.05% 97.65% 100.00%
ROE 17.42 % 18.00 % 15.81 % 14.96 % 19.23 % 17.84 % 17.19 % 0.89%
  QoQ % -3.22% 13.85% 5.68% -22.20% 7.79% 3.78% -
  Horiz. % 101.34% 104.71% 91.97% 87.03% 111.87% 103.78% 100.00%
Per Share
31/01/12 31/10/11 31/07/11 30/04/11 31/01/11 31/10/10 31/07/10 CAGR
RPS 15.62 32.33 28.99 28.77 28.41 25.88 23.78 -24.38%
  QoQ % -51.69% 11.52% 0.76% 1.27% 9.78% 8.83% -
  Horiz. % 65.69% 135.95% 121.91% 120.98% 119.47% 108.83% 100.00%
EPS 2.47 5.25 4.40 4.05 4.90 4.63 4.36 -31.46%
  QoQ % -52.95% 19.32% 8.64% -17.35% 5.83% 6.19% -
  Horiz. % 56.65% 120.41% 100.92% 92.89% 112.39% 106.19% 100.00%
DPS 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
  QoQ % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
NAPS 0.1417 0.2917 0.2784 0.2708 0.2546 0.2597 0.2535 -32.07%
  QoQ % -51.42% 4.78% 2.81% 6.36% -1.96% 2.45% -
  Horiz. % 55.90% 115.07% 109.82% 106.82% 100.43% 102.45% 100.00%
Adjusted Per Share Value based on latest NOSH - 333,740
31/01/12 31/10/11 31/07/11 30/04/11 31/01/11 31/10/10 31/07/10 CAGR
RPS 15.61 16.12 14.45 14.29 14.14 12.70 11.62 21.68%
  QoQ % -3.16% 11.56% 1.12% 1.06% 11.34% 9.29% -
  Horiz. % 134.34% 138.73% 124.35% 122.98% 121.69% 109.29% 100.00%
EPS 2.47 2.62 2.20 2.01 2.44 2.27 2.13 10.35%
  QoQ % -5.73% 19.09% 9.45% -17.62% 7.49% 6.57% -
  Horiz. % 115.96% 123.00% 103.29% 94.37% 114.55% 106.57% 100.00%
DPS 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
  QoQ % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
NAPS 0.1416 0.1454 0.1388 0.1345 0.1267 0.1274 0.1239 9.28%
  QoQ % -2.61% 4.76% 3.20% 6.16% -0.55% 2.82% -
  Horiz. % 114.29% 117.35% 112.03% 108.56% 102.26% 102.82% 100.00%
Price Multiplier on Financial Quarter End Date
31/01/12 31/10/11 31/07/11 30/04/11 31/01/11 31/10/10 31/07/10 CAGR
Date 31/01/12 31/10/11 29/07/11 29/04/11 31/01/11 29/10/10 30/07/10 -
Price 0.2200 0.2200 0.4200 0.2500 0.2300 0.1600 0.1500 -
P/RPS 1.41 0.68 1.45 0.87 0.81 0.62 0.63 70.85%
  QoQ % 107.35% -53.10% 66.67% 7.41% 30.65% -1.59% -
  Horiz. % 223.81% 107.94% 230.16% 138.10% 128.57% 98.41% 100.00%
P/EPS 8.91 4.19 9.54 6.17 4.70 3.45 3.44 88.28%
  QoQ % 112.65% -56.08% 54.62% 31.28% 36.23% 0.29% -
  Horiz. % 259.01% 121.80% 277.33% 179.36% 136.63% 100.29% 100.00%
EY 11.22 23.87 10.48 16.21 21.29 28.95 29.06 -46.88%
  QoQ % -53.00% 127.77% -35.35% -23.86% -26.46% -0.38% -
  Horiz. % 38.61% 82.14% 36.06% 55.78% 73.26% 99.62% 100.00%
DY 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
  QoQ % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
P/NAPS 1.55 0.75 1.51 0.92 0.90 0.62 0.59 90.06%
  QoQ % 106.67% -50.33% 64.13% 2.22% 45.16% 5.08% -
  Horiz. % 262.71% 127.12% 255.93% 155.93% 152.54% 105.08% 100.00%
Price Multiplier on Announcement Date
31/01/12 31/10/11 31/07/11 30/04/11 31/01/11 31/10/10 31/07/10 CAGR
Date 22/03/12 23/12/11 21/09/11 23/06/11 23/03/11 23/12/10 30/09/10 -
Price 0.2600 0.2000 0.1900 0.2400 0.2200 0.1900 0.1500 -
P/RPS 1.66 0.62 0.66 0.83 0.77 0.73 0.63 90.43%
  QoQ % 167.74% -6.06% -20.48% 7.79% 5.48% 15.87% -
  Horiz. % 263.49% 98.41% 104.76% 131.75% 122.22% 115.87% 100.00%
P/EPS 10.54 3.81 4.32 5.92 4.49 4.10 3.44 110.52%
  QoQ % 176.64% -11.81% -27.03% 31.85% 9.51% 19.19% -
  Horiz. % 306.40% 110.76% 125.58% 172.09% 130.52% 119.19% 100.00%
EY 9.49 26.26 23.17 16.88 22.25 24.38 29.06 -52.48%
  QoQ % -63.86% 13.34% 37.26% -24.13% -8.74% -16.10% -
  Horiz. % 32.66% 90.36% 79.73% 58.09% 76.57% 83.90% 100.00%
DY 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
  QoQ % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
P/NAPS 1.83 0.69 0.68 0.89 0.86 0.73 0.59 112.24%
  QoQ % 165.22% 1.47% -23.60% 3.49% 17.81% 23.73% -
  Horiz. % 310.17% 116.95% 115.25% 150.85% 145.76% 123.73% 100.00%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.


NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ Δ & YoY Δ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.



  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
MQ Trader
View Trading Signals and run Live Backtest
MQ Affiliate
Earn rewards with MQ Affiliate Program
 
 

236  475  591  1149 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 AT 0.095+0.005 
 VC 0.05-0.005 
 MAHSING 0.975-0.025 
 DATAPRP 0.20-0.02 
 KSTAR 0.445+0.075 
 LUSTER 0.165-0.005 
 SUPERMX-C1I 0.15-0.005 
 DGSB 0.22+0.005 
 SUPERMX 9.59-0.19 
 VIVOCOM 0.0450.00 

FEATURED POSTS

1. The Equity Market Index Benchmark in Malaysia CMS
2. Trading Scenarios of Derivatives Bursa Derivatives Education Series
3. Derivatives 101 Bursa Derivatives Education Series
4. Why Trade FKLI? Bursa Derivatives Education Series
5. MQ Trader - Introduction to MQ Trader Affiliate Program MQ Trader Announcement!

TOP ARTICLES

1. Supermax: my revised target price - Koon Yew Yin Koon Yew Yin's Blog
2. A LOOK AT CALVIN TAN RESEARCH STOCK PICKS (AS RECORDED BY PHILIP NOT PERFECTLY BUT CLEAR ENOUGH THE INVESTMENT APPROACH OF CALVIN TAN
3. Supermax: The Best Is Yet To Come- Myth or Truth Van Gogh of Financial
4. US has 2 Incurable Chronic Diseases - Koon Yew Yin Koon Yew Yin's Blog
5. Najib Facebook Post comments on GLOVES. What's the message? gloveharicut
6. LUXCHEM RESULT VERSUS HARTALEGA RESULT (COMPARE & CONTRAST) Calvin Tan Research THE INVESTMENT APPROACH OF CALVIN TAN
7. [Humbled Investor] Supermx - Superb results - Estimation on Next QR Results HumbledInvestor
8. DOW CRASHED BY 650 POINTS ? NO FEAR AT ALL IF YOU KNOW THIS STOCK PROSPERED DURING ASIAN FINANCIAL CRISIS & SUBPRIME CRISIS OF 2007/8 COLLAPSE (WHAT? THE INVESTMENT APPROACH OF CALVIN TAN
PARTNERS & BROKERS